APYX Stock Analysis: Buy, Sell, or Hold?
APYX - Apyx Medical Corporation Common Stock
$3.83
-0.08 (-2.05%)
▼
5d:
-11.75%
30d:
-6.13%
90d:
+0.0%
WAIT
LOW Confidence
Analysis Updated: Jul 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026
12d
Get Alerted When APYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: APYX is down 11.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: APYX is down 11.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: APYX is currently trading at $3.83, which is considered oversold relative to its 30-day fair value range of $4.06 to $4.48.
Technical Outlook: Technically, APYX is in a uptrend. The price is currently testing key support at $3.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.60 (+72.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APYX is in a uptrend. The price is currently testing key support at $3.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.60 (+72.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.06 -
$4.48
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 72.3% below Wall St target ($6.60)
- WARNING: Recommendation downgraded due to -11.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$4.06 -
$4.48
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.83
Resistance Level
$4.50
Current Trend
Uptrend
Technical data as of
Jul 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.32
Wall Street Target
$6.60
(+72.3%)
Revenue Growth (YoY)
32.5%
Profit Margin
-16.4%
Share & Embed Analysis
Last updated: July 24, 2026 12:21 AM ET
Data refreshes hourly during market hours. Next update: 1:21 AM
Data refreshes hourly during market hours. Next update: 1:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$86 | 44 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 49 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 56 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$238 | 42 HOLD |
